Innovation drives our strategy. Perseverance propels our success.

Genus Lifesciences™ is a specialty pharmaceutical company engaged in the development and commercialization of generic and branded pharmaceutical products. Founded in 1999, Genus Lifesciences™ employs over one hundred fifty professionals in all phases of pharmaceutical operations, and its products are available in pharmacies and other retail outlets throughout the United States. In addition to its local presence, Genus Lifesciences™ has on-going research efforts through global partnerships related to its technology platforms.
The Science of Possibility
Genus Lifesciences™ founded in 1999
Analytical Laboratory
Quality Systems
Research & development
Production


NDA
Genus Lifesciences is a national leader in the submission of 505(b)(2) New Drug Applications, for products previously sold as Unapproved Products.



DART
Diversion and Abuse Resistant Technologies (DART) allows dosage manufacturers to improve a product’s resistance to abuse, illegal diversion, and potential overdose.

Learn more about it

Pipeline
Genus Lifesciences™ has a rigorous R&D program. With global reach, Genus Lifesciences'™ R&D plan benefits from the vast intellectual resources and partnerships with foreign and domestic companies.

Learn more about it